← 治験一覧に戻る
常染色体優性多発性嚢胞腎患者を対象とした観察研究
基本情報
- NCT ID
- NCT01430494
- ステータス
- 完了
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 3,409
- 治験依頼者名
- Otsuka Pharmaceutical Development & Commercialization, Inc.
概要
To collect characteristics of patients with ADPKD across a broad population, over time to better understand disease progression (signs, symptoms and outcomes). Association with total kidney volume changes and other measures of disease progression will be determined in order to identify a population at increased risk for disease progression. The economic and quality life impact of ADPKD will be assessed. Subjects who terminated participation early from clinical trials with tolvaptan may also be followed.
対象疾患
Autosomal Dominant Polycystic Kidney Disease (ADPKD)